|
|
||||||||
Animal: RNA Viruses |
Division of Clinical Virology, Karolinska Institute, F68, Huddinge University Hospital, S-141 86 Huddinge, Stockholm, Sweden1
Department of Medical Biochemistry and Microbiology, BMC, Uppsala University, S-751 23 Uppsala, Sweden2
Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, 1230 York Avenue, New York 10021-6399, USA3
Author for correspondence: Mojgan H. Naghavi. Fax +46 8 585 87933. e-mail Mojgan.Naghavi{at}impi.ki.se
Human immunodeficiency virus type 1 (HIV-1) is classified into subtypes on the basis of phylogenetic analysis of sequence differences. Inter- and intra-subtype polymorphism extends throughout the genome, including the long terminal repeat (LTR). In this study, the importance of the upstream stimulating factor (USF)-binding site (E-box) in the core-negative regulatory element (NRE) of the LTR of HIV-1 subtypes A, B, C, D, E and G was investigated. In vivo, USF was found to repress transcription directed from representative HIV-1 LTR sequences of all the subtypes tested in an epithelial cell line, yet activate the same transcription in a T-cell line. Mutation of the core-NRE USF site of the representative subtype B LTR did not affect the cell-specific, subtype-independent, dual role of USF. In vitro binding assays showed that recombinant USF43 interacts with the core-NRE from subtypes B and C, but not A, D, E or G. Thus, USF affects LTR-directed transcription in a cell-specific manner, independently of both the HIV-1 subtype from which the LTR was derived and the core-NRE USF site sequences.
This article has been cited by other articles:
![]() |
X. Che, B. Berarducci, M. Sommer, W. T. Ruyechan, and A. M. Arvin The Ubiquitous Cellular Transcriptional Factor USF Targets the Varicella-Zoster Virus Open Reading Frame 10 Promoter and Determines Virulence in Human Skin Xenografts in SCIDhu Mice In Vivo J. Virol., April 1, 2007; 81(7): 3229 - 3239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, T. Malcolm, M. C. Estable, R. G. Roeder, and I. Sadowski TFII-I Regulates Induction of Chromosomally Integrated Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Cooperation with USF J. Virol., April 1, 2005; 79(7): 4396 - 4406. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. van Opijnen, J. Kamoschinski, R. E. Jeeninga, and B. Berkhout The Human Immunodeficiency Virus Type 1 Promoter Contains a CATA Box Instead of a TATA Box for Optimal Transcription and Replication J. Virol., July 1, 2004; 78(13): 6883 - 6890. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. van Opijnen, R. E. Jeeninga, M. C. Boerlijst, G. P. Pollakis, V. Zetterberg, M. Salminen, and B. Berkhout Human Immunodeficiency Virus Type 1 Subtypes Have a Distinct Long Terminal Repeat That Determines the Replication Rate in a Host-Cell-Specific Manner J. Virol., April 1, 2004; 78(7): 3675 - 3683. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rohr, C. Marban, D. Aunis, and E. Schaeffer Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells J. Leukoc. Biol., November 1, 2003; 74(5): 736 - 749. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |